Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Focetria H1N1 vaccine in rheumatic disease patients
NCT01006681Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Nov 2009
- Primary completion
- Apr 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
01
Overview
A Phase 2 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza, sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01006681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006681.